Testing effectiveness (Phase 2)Ended earlyNCT00027508What this trial is testingEcteinascidin 743 in Treating Patients With Malignant MesotheliomaWho this might be right forMalignant Mesothelioma PharmaMar
Testing effectiveness (Phase 2)Active Not RecruitingNCT04071223What this trial is testingTesting the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL StudyWho this might be right forAdvanced Renal Cell CarcinomaChromophobe Renal Cell CarcinomaClear Cell Renal Cell Carcinoma+6 more National Cancer Institute (NCI) 134
Early research (Phase 1)Study completedNCT01286896What this trial is testingUse of Individual Pharmacokinetically (PK)-Guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid TumorsWho this might be right forMalignant Solid Tumour The Netherlands Cancer Institute 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439279What this trial is testingTesting Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 35
Large-scale testing (Phase 3)Study completedNCT00190762What this trial is testingA Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of MesotheliomaWho this might be right forMesothelioma Eli Lilly and Company 240
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439227What this trial is testingTesting AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 33
Testing effectiveness (Phase 2)Study completedNCT00017186What this trial is testingGemcitabine and Epirubicin in Treating Patients With Malignant MesotheliomaWho this might be right forMalignant Mesothelioma Alliance for Clinical Trials in Oncology 69
Testing effectiveness (Phase 2)Study completedNCT00019331What this trial is testingVaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsWho this might be right forColorectal CancerEndometrial CancerHead and Neck Cancer+6 more National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT03203525What this trial is testingCombination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic CancerWho this might be right forAdvanced Malignant NeoplasmColorectal Carcinoma Metastatic in the LiverMetastatic Malignant Neoplasm in the Liver+1 more M.D. Anderson Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT01983124What this trial is testingVemurafenib + Fotemustine to Treat Advanced Melanoma Patients With V600BRAF Mutation Recurred While on VemurafenibWho this might be right forMalignant Melanoma Stage IV Paola Queirolo 31
Not applicableStudy completedNCT05495308What this trial is testing"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".Who this might be right forRectal Cancer, AdenocarcinomaRectal Cancer Stage IIRectal Cancer Stage III+2 more Hospital San Carlos, Madrid 4
Testing effectiveness (Phase 2)Study completedNCT03792750What this trial is testingBMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Solid TumorsWho this might be right forAdvanced Cancer Bristol-Myers Squibb 12
Not applicableWithdrawnNCT03592459What this trial is testingRectal Administration of Opioids Using the Macy Catheter in Reducing Pain in Patients With Advanced CancerWho this might be right forAdvanced Malignant NeoplasmPain M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT05501340What this trial is testingPD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant AscitesWho this might be right forMalignant Ascites Second Affiliated Hospital of Soochow University 40
Early research (Phase 1)Ended earlyNCT05840510What this trial is testingAdagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19)Who this might be right forSolid Tumor, AdultNSCLCAdvanced Cancer+2 more Mirati Therapeutics Inc. 6
Testing effectiveness (Phase 2)Study completedNCT00458913What this trial is testingBortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant MesotheliomaWho this might be right forMalignant Mesothelioma European Organisation for Research and Treatment of Cancer - EORTC 82
Very early researchLooking for participantsNCT06937567What this trial is testingCDH17 CAR-T Therapy in Advanced Malignant Solid TumorsWho this might be right forBiliary Tract CancerColorectal CarcinomaGastric Cancer, Metastatic+2 more Zhejiang University 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299What this trial is testingTocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more M.D. Anderson Cancer Center 35
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Early research (Phase 1)Study completedNCT00732992What this trial is testingA Safety Study Of Sunitinib In Combination With Pemetrexed In Patients With Advanced Solid MalignanciesWho this might be right forNeoplasm, Malignant Pfizer 12